Palonosetron hydrochloride is a selective 5-HT3 receptor antagonist utilized to prevent chemotherapy-induced nausea and vomiting. It is widely employed in both in vitro binding studies and in vivo animal models to investigate antiemetic mechanisms and efficacy.
